Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
spinal muscular atrophy
Pharma
Novartis readies intrathecal Zolgensma for older SMA patients
FDA filing for intrathecal Zolgensma is planned for first-half 2025 after a positive phase 3 readout.
Angus Liu
Jan 2, 2025 12:30pm
Biogen reports promising results for higher dose of Spinraza
Oct 9, 2024 7:30am
Biogen to seek approval for high-dose version of Spinraza
Sep 4, 2024 11:45am
Genentech takes SMA song ‘Spaces’ to the White House
Jul 30, 2024 11:22am
Biogen, Delta collab to improve accessibility in air travel
Jun 4, 2024 11:11am
Genentech creates 'edgy' musical comedy with the SMA community
Feb 15, 2024 7:15am
